YPrime
PrivateLast Round
Follow-on Offering
Dec 11, 2019
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
YPrime operates in Healthcare & Life Sciences and is based in Malvern, Pennsylvania. Its latest recorded funding round was a Private Equity round in February 2019.
YPrime is a healthcare technology company that provides cloud-based software solutions, including eCOA, IRT, and eConsent platforms, to manage data for clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YPrime Comparables
Compare YPrime with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| THREAD | 91% | |
| Clinical Ink | 88% | |
| Medrio | 87% |
For institutional investors. Book with your work email.
YPrime Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Dec 11, 2019 | ||||
| Private Equity | Feb 5, 2019 | ||||
| Growth Equity | Nov 9, 2017 | ||||
| Debt | Jun 14, 2016 | ||||
| Series A | Sep 7, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
YPrime Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Square 1 Bank | Debt |
| Topmark Partners | Growth Equity |
| Flexpoint Ford | Private Equity |
| Ballast Point Ventures | Private Equity, Growth Equity, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 42% MoM, reaching 8.4K.
- Nov 19, 2025
Deployed eCOA solution for rare disease trial customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asAug 10, 2026
On Aug 10th '26 in Pennsylvania, Everest Group names YPrime, Inc. to its Top 50(TM) Pharmaceutical Technology Providers list, an annual ranking of technology companies with the greatest measured impact across the pharmaceutical value chain.
For institutional investors. Book with your work email.
YPrime Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about YPrime's valuation, stock price, and market status.
Is YPrime a public or private company?
YPrime is a private company.
What is the current stock price of YPrime?
YPrime is a private company, so its shares have no public market price. Caplight tracks YPrime's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is YPrime worth (valuation)?
Valuation information for YPrime is not publicly available.
Can I buy YPrime stock?
YPrime shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was YPrime's last funding round?
YPrime's most recent funding round was Follow-on Offering on December 11, 2019.
Who are the main investors in YPrime?
Key investors in YPrime include Square 1 Bank, Flexpoint Ford, Ballast Point Ventures.
Will YPrime IPO soon?
No public IPO plans have been announced for YPrime.
How can I track YPrime secondary market activity?
Caplight tracks bids, offers, and trades in YPrime's shares on secondary markets.